CBDA, THCA, CBGA, and CBCA degrade quickly after purification. Light, heat, and oxygen convert them into less potent compounds, and in the case of THCA, psychoactive ones, before your product reaches a consumer. When that happens, your label claims no longer reflect what is in the bottle, and your shelf life is compromised.
Mingowood Pharmacal’s Intercalyx™ platform fixes this. Our patented formulation intercalates acidic cannabinoids into layered double hydroxides, forming a stable matrix that inhibits decarboxylation and oxidation. The outcome is consistent potency, accurate dosing, a shelf life of more than 2 years, and no cold-chain requirement.
What this means for your products
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.